Maintenance of the response to dimethyl sulfoxide treatment using hyperbaric oxygen in interstitial cystitis/painful bladder syndrome: A prospective, randomized, comparative study

Urologia Internationalis

Volumn 90, Issue 4, 2013, Pages 411-416

  Gallego Vilar, Daniel ^a   García Fadrique, Gonzalo ^c   Povo Martin, Ivan ^a   Salvador Marin, Manuel ^b   Gallego Gomez, Juan ^a  

^a Castellon University General Hospital   (Spain)

^b HOSPITAL GENERAL DE CASTELLÓN   (Spain)

^c Hospital Manises   (Spain)

Author keywords

Dimethyl sulfoxide; Hyperbaric oxygen; Interstitial cystitis; Painful bladder

Indexed keywords

ANALGESIC AGENT; ANTIHISTAMINIC AGENT; BICARBONATE; DIMETHYL SULFOXIDE; HEPARIN; HYDROCORTISONE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PENTOSAN POLYSULFATE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AQUEOUS SOLUTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTOSCOPY; FEMALE; FOLLOW UP; HUMAN; HYPERBARIC OXYGEN; INTERSTITIAL CYSTITIS; KING'S HEALTH QUESTIONNAIRE; MAINTENANCE THERAPY; NOCTURIA; O'LEARY SANT INTERSTITIAL CYSTITIS SCORE; OPEN STUDY; PILOT STUDY; PRIORITY JOURNAL; PROBLEM INDEX; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT DURATION; TREATMENT RESPONSE; URINARY FREQUENCY; URINARY URGENCY; VISUAL ANALOG SCALE;

EID: 84879156492     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000343697     Document Type: Article

References (24)

1. Abrams PH, Cardozo L, Fall M, et al: The standardization of terminology of lower urinary tract function: report from the standardization sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21: 167-178.
2. Wein AJ, Hanno PM, Gillenwater JY: Interstitial cystitis: an introduction to the problem; in Hanno PM, Staskin DR, Krane RJ, Wein AJ (eds): Interstitial Cystitis. London, Springer, 1990, pp 3-15.
3. Van de Merwe J, Nordling J, Bouchelouche P, et al: Diagnostic criteria, classification and nomenclature for painful bladder syndrome/ interstitial cystitis: an ESSIC proposal. Eur Urol 2008; 53: 60-67.
4. Parsons CL: Bladder surface glycosaminoglycan: efficient mechanism of environmental adaptation. Urology 1986; 27(suppl 2):9-14.
5. Dawson TE, Jamison J: Intravesical treatments for painful bladder syndrome/interstitial cystitis. Cochrane Database Syst Rev 2007; 4:CD006113.
6. Gallego Villar D, García Fadrique G, Povo Martín IJ, Miralles Aguado J, Garau Perelló C, Sanchis Verdú L, Gimeno Argente V, Bosquet Sanz M, Rodrigo Aliaga M, Claramonte Ramón FJ, Gallego Gómez J: Hyperbaric oxygen treatment in urology. Arch Esp Urol 2011; 64: 507-516.
7. Thilagarajah R, Witherow RO, Walker MM: Oral cimetidine gives effective symptom relief in painful bladder disease: a prospective, randomized double blind placebo-controlled trial. BJU Int 2001; 87: 207-212.
8. Mulholland SG, Hanno P, Parsons CL, Sant GR, Staskin DR: Pentosan polysulfate sodium for therapy of interstitial cystitis. A doubleblind placebo-controlled clinical study. Urology 1990; 35: 552-558.
9. Sant GR, Propert KJ, Hanno PM, Burks D, Culkin D, Djokno AC, et al: Interstitial cystitis group. A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. Urology 2003; 170: 810-815.
10. Lee JW, Han DY, Jeong HJ: Bladder pain syndrome treated with triple therapy with gabapentin, amitriptyline, and a non-steroidal anti-inflammatory drug. Int Neurourol J 2010; 14: 256-260.
11. Takahashi S, Yanase M, Inoue R, Ichihara K, Masumori N, Tsukamoto T, et al: Intravesical instillation of resiniferatoxin for the patients with interstitial cystitis. Hinyokika Kiyo 2006; 52: 911-913.
12. Peng CH, Kuo HC: Multiple intravesical instillations of low-dose resiniferatoxin in the treatment of refractory interstitial cystitis. Urol Int 2007; 78: 78-81.
13. Payne CK, Mosbaugh PG, Forrest JB, Evans RJ, Whitmore KE, Antoci JP, et al: Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo-controlled trial. J Urol 2005; 173: 1590-1594.
14. Mayer R, Propert KJ, Peters KM, Payne CK, Zhang Y, Burks D, et al: A randomized controlled trial of intravesical bacillus Calmette-Guérin for treatment refractory interstitial cystitis. J Urol 2005; 173: 1186-1191.
15. Engelhardt PF, Morakis N, Daha LK, Esterbauer B, Riedl CR: Long-term results of intravesical hyaluronan therapy in bladder pain syndrome/interstitial cystitis. Int Urogynecol J 2011; 22: 401-405.
16. Giannantoni A, Cagini R, Del Zingaro M, Proietti S, Quartesan R, Porena M, Piselli M: Botulinum A toxin intravesical injections for painful bladder syndrome: impact upon pain, psychological functioning and quality of life. Curr Drug Deliv 2010; 7: 442-446.
17. Peters KM, Carey JM, Konstandt DB: Sacral neuromodulation for the treatment of refractory interstitial cystitis: outcomes based on technique. Int Urogynecol J Pelvic Floor Dysfunct 2003; 14: 223-228.
18. Parson CL: Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis. Urology 2005; 65: 45-48.
19. Perez-Marrero R, Emerson LE, Feltis JT: A controlled study of dimethyl sulfoxide in interstitial cystitis. J Urol 1988; 140: 36-39.
20. Tanaka T, Nitta Y, Morimoto K, Nishikawa N, Nishihara C, Tamada S, Kawashima H, Nakatani T: Hyperbaric oxygen therapy for painful bladder syndrome/interstitial cystitis resistant to conventional treatments: long-term results of a case series in Japan. BMC Urol 2011; 11: 11.
21. Tanaka T, Kawashima H, Makino T, Kamikawa S, Kato N, Nakatani T: Hyperbaric oxygen therapy for interstitial cystitis resistant to conventional treatments. Int J Urol 2007; 14: 563-565.
22. Van Ophoven A, Rossbach G, Oberpenning F, Hertle L: Hyperbaric oxygen for the treatment of interstitial cystitis: long-term results of a prospective pilot study. Eur Urol 2004; 46: 108-113.
23. Van Ophoven A, Rossbach G, Pajonk F, Hertle L: Safety and efficacy of hyperbaric oxygen therapy for the treatment of interstitial cystitis: a randomized, sham controlled, doubleblind trial. J Urol 2006; 176: 1442-1446.
24. Milovanova TN, Bhopale VM, Sorokina EM, Moore JS, Hunt TK, Hauer-Jensen M, et al: Hyperbaric oxygen stimulates vasculogenic stem cell growth and differentiation in vivo. Appl Physiol 2009; 106: 711-728.